mCRC: Optimising patient outcomes with late-line treatment

What treatment options are available for patients with metastatic colorectal cancer who have already progressed through multiple lines of therapy?  How can we select the right treatment for the right patient?  Medical oncologists Assoc. Prof. Gerald Prager (Austria) and Dr Victor Hugo Fonseca de Jesus draw from their own clinical expertise and data from clinical trials to provide their perspectives on these questions.  They discuss how to manage side effects from available treatments to maximise survival benefit whilst maintaining quality of life and consider what the future holds for later-line treatment in metastatic colorectal cancer. Prefer to watch as well as listen? Watch a video of the experts in conversation and download the full transcript on the COR2ED website: https://cor2ed.com/gi-connect/programmes/patient-outcomes-mcrc/ Or go to the video on YouTube: https://youtu.be/ftjskGynDIc We are pleased to share that this podcast is endorsed by Bayer The medical experts in this podcast are expressing their own views and not those of COR2ED, supporters, or their institution. This podcast is supported by an Independent Medical Education Grant from Bayer. This educational podcast is developed by cor2ed.com

There are no comments yet.

Please log in to write the first comment.